Summary
In a significant market movement during June 2022, Spirea was the subject of a vc funding. The transaction achieved a gross valuation of £2,485,017. Leading the round was ACF investors, Syndicate Room, R42 Group, Cambridge Enterprise, Cambridge Angels, o2h Ventures, Jonathan Milner.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
ACF investors
Lead Investor / Acquirer
Syndicate Room
Lead Investor / Acquirer
R42 Group
Lead Investor / Acquirer
Cambridge Enterprise
Lead Investor / Acquirer
Cambridge Angels
Lead Investor / Acquirer
o2h Ventures
Lead Investor / Acquirer
Jonathan Milner
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in